home / stock / qsam / qsam news


QSAM News and Press, QSAM Biosciences Inc From 12/08/22

Stock Information

Company Name: QSAM Biosciences Inc
Stock Symbol: QSAM
Market: OTC
Website: qsambio.com

Menu

QSAM QSAM Quote QSAM Short QSAM News QSAM Articles QSAM Message Board
Get QSAM Alerts

News, Short Squeeze, Breakout and More Instantly...

QSAM - Doing Crossword Puzzles Helps Sharpen Memory Better Than Computer Games

Researchers have discovered that crossword puzzles help to better sharpen memory in older individuals suffering from mild cognitive impairment, in comparison to computer games. While crossword puzzles are popularly used, no research has systematically studied them and their association with mil...

QSAM - Research Discovers That Survivors of Pediatric Cancer Are Prone to Premature Aging

Every year, an estimated 400 children and adolescents aged 19 and under are diagnosed with cancer. Leukemia, brain tumors, solid tumors such as neuroblastomas and lymphomas tend to be the most common types of pediatric cancer, with more than 80% of patients in high-income nations such as the ...

QSAM - Type 2 Diabetes Patients Are Diagnosed Late If They Develop Cancer

Early diagnosis is critical for positive outcomes in cancer. Although there is no effective cure for cancer, early diagnosis allows physicians to deploy treatments such as surgery, radiation and chemotherapy that can reduce the size of the tumor and increase life expectancy. Research shows...

QSAM - Cancer Care Adhering to Guidelines Could Help Reduce Treatment Disparities

Even though we have come a long way from the days of slavery, racial discrimination and disparities are still entrenched in American society. In many cases, racial biases prevent people of color from receiving high-quality medical care, with some studies showing that Black Americans are of...

QSAM - QSAM Biosciences GAAP EPS of -$0.75

QSAM Biosciences press release ( OTCQB:QSAM ): Q3 GAAP EPS of -$0.75. As of September 30, 2022, we had cash on hand of $899,290, primarily from the closing of the first tranche of a common stock and warrant private placement. For further details see: QSAM Biosciences...

QSAM - QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update

Further Progress Demonstrated in Clinical Program Evaluating CycloSam ® Radiopharmaceutical Drug Candidate for Treatment of Metastatic Bone Cancer AUSTIN, Texas, Nov. 15, 2022 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company develop...

QSAM - New Discovery May Improve Prospects for Patients with Cancer

CDC data shows that cancer death rates have been dropping for the last two decades, with a decline of 27% being recorded in the period between 2001–2020. Researchers believe that this can be attributed to improvements in current cancer treatment and diagnostic procedures as well as ...

QSAM - Study Finds Epigenetics May Revolutionize Treatment of Cancer

A new study has led to the discovery of new information about the role of epigenetics in cancer development. Epigenetics refers to the study of how an individual’s environment and behaviors cause changes that affect the way their genes work. The study, which was conducted by scien...

QSAM - InvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Announces Approval of Second Clinical Trial Site for Phase 1 Study

QSAM Biosciences (OTCQB: QSAM) , a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has added Rutgers Cancer Institute of New Jersey (“RCINJ”) as a clinical...

QSAM - QSAM Biosciences Adds Rutgers Cancer Institute of New Jersey as Clinical Trial Site To Expand and Advance Study of CycloSam® in the Treatment of Bone Cancer

Austin, TX, Oct. 26, 2022 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM), a company developing next generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam ® ), for the treatment of bone cancer and related diseases and conditions, today ann...

Previous 10 Next 10